Chembio Diagnostics, Inc.
USD0.46
+0.00 (+0.22%)
CEO
Richard L. Eberly
IPO Date
2000-10-18
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Country
US
Open
$0.45
Prev. Close
$0.45
Day Low
$0.46
Day High
$0.46
52W Low
$0.19
52W High
$1.24
Market Cap
$0.02B
Volume
0.35M
| -0.8 |
| 31 Dec 2020 | FY | 21.6% | -83.8% | -91.9% | -39.3% | 0.91 | 3.22 | -3.6 |
| 31 Dec 2019 | FY | 35.0% | -39.7% | -56.9% | -24.5% | 1.06 | 5.00 | -5.7 |
| 31 Dec 2018 | FY | 35.9% | -23.5% | -23.6% | -19.2% | 0.01 | 4.36 | -10.4 |
| 31 Dec 2017 | FY | 46.2% | -26.5% | -48.7% | -38.3% | 0.01 | 3.51 | -15.8 |
| 31 Dec 2016 | FY | 47.3% | -74.7% | -77.7% | -64.9% | 0.00 | 5.32 | -5.4 |
| 31 Dec 2015 | FY | 43.2% | -9.9% | -13.6% | -11.5% | 0.00 | 4.00 | -21.4 |
| 31 Dec 2014 | FY | 39.1% | -4.1% | -5.8% | -4.5% | 0.00 | 3.34 | -32.8 |
| 31 Dec 2013 | FY | 41.6% | 1.8% | 2.6% | 2.2% | 0.00 | 4.30 | 57.1 |
| -0.4 |
| 30 Jun 2022 | Q2 | 11.7% | -75.8% | -34.9% | -12.4% | 1.31 | 2.92 | -0.7 |
| 31 Mar 2022 | Q1 | 19.1% | -46.7% | -33.1% | -14.0% | 0.97 | 3.54 | -0.7 |
| 31 Dec 2021 | Q4 | -7.3% | -78.9% | -40.8% | -19.1% | 0.75 | 3.59 | -0.6 |
| 30 Sept 2021 | Q3 | 18.2% | -65.9% | -13.3% | -7.6% | 0.54 | 5.32 | -2.6 |
| 30 Jun 2021 | Q2 | 3.4% | -216.7% | -60.0% | -18.3% | 1.72 | 2.69 | -1.7 |
| 31 Mar 2021 | Q1 | 34.0% | -83.7% | -19.3% | -7.8% | 1.09 | 3.42 | -3.9 |
| 31 Dec 2020 | Q4 | 22.5% | -87.0% | -25.7% | -11.0% | 0.91 | 3.22 | -3.4 |
| 30 Sept 2020 | Q3 | 27.3% | -53.9% | -16.3% | -7.9% | 0.75 | 4.07 | -4.4 |